3,6-Diphenylpyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione, 95.0%, 25g

5-BROMO-4-METHYL-2-(METHYLSULFONYL)PYRIDINE, 95.0%, 250mg

1,2,3,4-Tetrahydro-2,7-naphthyridine hydrochloride, 95.0%, 5g

2-Bromo-N-methylbenzenesulfonamide, 95.0%, 1g

Balicatib, 98%, 250mg

(2R,3S)-2-(Hydroxymethyl)-5-methoxytetrahydrofuran-3-ol, 95.0%, 25g

3-Amino-1-ethylpiperidine-2,6-dione, 98%, 500mg

2-((Tert-butoxycarbonyl)amino)-3-(3-hydroxyphenyl)propanoic acid, 97%, 5g

6-Chlorohexanoic Acid>98.0%(GC)(T)25g

2H-Imidazo[4,5-c]quinolin-2-one, 7-(3,5-dimethyl-4-isoxazolyl)-1,3-dihydro-8-methoxy-1-[(1R)-1-(2-pyridinyl)ethyl]-, 98%, 10mg

4-Bromo-1H-imidazole-2-carboxylic acid, 95.0%, 50mg

Ethyl 8-(4-t-butylphenyl)-8-oxooctanoate, 97.0%, 1g

2-Methyl-5-(pyridin-2-yl)aniline, 95%, 100mg